Mitochondrial Peptides & Metabolic Compounds
Bioenergetics · AMPK · Sirtuin Activation · Cardiolipin
The mitochondrial and metabolic compound family groups research tools that target cellular energy metabolism at its most fundamental levels: the electron transport chain, cardiolipin membrane dynamics, mitochondrial-derived peptide signaling, NAD+-dependent enzyme regulation, and nicotinamide methylation pathways. These compounds have collectively become central tools in aging biology, metabolic disease, and bioenergetics research.
Compounds in This Family
MOTS-c
Mitochondrial ORF of the 12S rRNA type-c, Mitochondrial-Derived Peptide
Overview
SS-31 (Elamipretide) concentrates in the inner mitochondrial membrane and protects cardiolipin from oxidative damage, stabilizing ETC supercomplexes and improving ATP synthesis efficiency. MOTS-c is a mitochondrially-encoded peptide that signals from mitochondria to the nucleus to activate AMPK and reprogram metabolic gene expression. NAD+ is the universal cellular electron carrier and substrate for sirtuin deacetylases and PARP repair enzymes. 5-Amino-1MQ inhibits NNMT, an enzyme that depletes nicotinamide substrate for NAD+ synthesis and impairs the methionine cycle in obese adipose tissue.
These four compounds address complementary nodes of the same metabolic network: SS-31 at the mitochondrial inner membrane, MOTS-c at the mitochondrion-to-nucleus communication axis, NAD+ at the substrate level for energy and regulatory enzymes, and 5-Amino-1MQ at the upstream biosynthesis bottleneck that determines NAD+ availability in metabolically stressed tissues.
Research Themes
Cardiolipin and ETC Supercomplex Biology
SS-31's mechanism of action — binding cardiolipin in the inner mitochondrial membrane to protect against oxidative damage and stabilize ETC respirasomes — has made it a model compound for studying how mitochondrial membrane lipid composition affects bioenergetic efficiency. Research with SS-31 in ischemia-reperfusion models, heart failure models, and aging skeletal muscle has provided mechanistic insights into how cardiolipin peroxidation contributes to mitochondrial dysfunction across multiple disease contexts.
Mitochondrial-Derived Peptides and Retrograde Signaling
MOTS-c was one of the first peptides discovered to be encoded within the mitochondrial genome rather than the nuclear genome, establishing the concept of mitochondria as active endocrine organs rather than passive energy factories. Its signaling pathway — inhibiting DHFR in the folate cycle to accumulate AICAR and activate AMPK — and its nuclear entry during metabolic stress to regulate Nrf2/ARE gene expression represent a fundamentally new type of organelle-to-nucleus crosstalk that continues to be an active research frontier.
NAD+ Biology and SIRT/PARP Regulation
NAD+ availability is a rate-limiting factor for both sirtuin deacetylases and PARP DNA repair enzymes. The age-associated decline in NAD+ levels has positioned NAD+ supplementation and restoration strategies as central topics in longevity research. 5-Amino-1MQ addresses NAD+ availability from the upstream side by inhibiting NNMT-mediated nicotinamide consumption, while direct NAD+ supplementation addresses the availability from the substrate side. Research combining these approaches provides mechanistic data on the relative importance of each bottleneck.
Compound Research Overviews
Frequently Asked Questions
How does SS-31 accumulate in the mitochondria?+
Unlike most mitochondria-targeted compounds that use lipophilic cations to leverage the mitochondrial membrane potential, SS-31 uses an unusual mechanism: its alternating cationic and aromatic amino acids allow it to interact with the negatively charged cardiolipin phosphate head groups directly in the inner mitochondrial membrane. This cardiolipin affinity drives approximately 1,000-fold concentration of SS-31 in the IMM relative to cytoplasm.
What makes MOTS-c different from nuclear-encoded metabolic peptides?+
MOTS-c is translated from a small open reading frame within the mitochondrial 12S rRNA gene — meaning its DNA sequence lives in mitochondria, not in chromosomal DNA. This makes it part of a new class called mitochondrial-derived peptides (MDPs). Its signaling pathway also has unique features: it enters the nucleus during metabolic stress and activates antioxidant response elements (ARE) through Nrf2, creating a direct communication channel from the organelle to the genome.
Why study 5-Amino-1MQ alongside NAD+?+
These compounds address the same NAD+ availability problem from different angles. NAD+ supplementation directly restores the coenzyme. 5-Amino-1MQ inhibits NNMT, which consumes nicotinamide — a precursor to NAD+ — in a futile methylation reaction that is upregulated in obese adipose tissue. Studying them together can reveal whether the bottleneck for NAD+ availability in a given tissue is upstream precursor supply (NNMT-addressable) or direct cofactor depletion (NAD+-addressable).
Research Use Only. All compounds in the Mitochondrial Peptides & Metabolic Compounds family are sold for laboratory and research applications only and are not approved for human or veterinary therapeutic use. Information presented on this page is derived from published preclinical and clinical research literature and is provided for educational and scientific context only.
Other Peptide Families